| Literature DB >> 32306165 |
Monique McKiever1, Heather Frey1, Maged M Costantine2.
Abstract
Maternal mortality and morbidity continue to rise in the United States. Despite these trends there are limited novel interventions to investigate and improve these metrics, partly due to research protocol limitations which restrict participation of pregnant women. Inclusion of pregnant women in research studies is integral to the process of obtaining important information regarding the safety and efficacy of therapeutics or interventions to improve maternal health and pregnancy outcomes. While significant changes in research practices have resulted in an increase of female participants, there remains a paucity of research trials directly targeting pregnant and lactating women. This article provides an overview of issues surrounding inclusion of pregnant or breastfeeding women in research studies, and includes historical perspectives, navigating concerns over safety profile, considerations for appropriate development, and future perspectives.Entities:
Keywords: Breastfeeding; Clinical research; Drug development; Obstetrics; Pharmacology; Pregnancy
Year: 2020 PMID: 32306165 PMCID: PMC8237366 DOI: 10.1007/s10928-020-09687-z
Source DB: PubMed Journal: J Pharmacokinet Pharmacodyn ISSN: 1567-567X Impact factor: 2.745